Effects of Lutein in Retinitis Pigmentosa

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2001

Study Completion Date

October 31, 2002

Conditions
Retinitis Pigmentosa
Interventions
DRUG

Lutein (10 or 30 mg/day) capsules

Trial Locations (1)

21205

Johns Hopkins Wilmer Eye Institute, Lions Vision Center, Baltimore

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00029289 - Effects of Lutein in Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter